Astellas extends offer period for OSI shares
This article was originally published in Scrip
Astellas has extended its tender offer for OSI Pharmaceuticals to midnight New York City time on 2 June, giving a few more weeks for investors to offer their shares. The already extended all-cash tender was originally set to expire on 17 May. The Japanese firm yesterday announced a definitive agreement to acquire OSI for around $4 billion, after it raised its offer price from $52.00 to $57.50 per share (scripnews.com, 17 May 2010).